Table 2

Baseline Characteristics of Patients According to the Clinical Profile

CharacteristicsClinical Profilesp Values
A (n = 123)B (n = 222)C (n = 91)L (n = 16)
Age, yrs55 ± 1456 ± 1555 ± 1350 ± 130.30
Male gender, %736771560.41
Ischemic cardiomyopathy, %534653440.53
Time since first diagnosis, months14 ± 2222 ± 3211 ± 1727 ± 460.14
Medications
 ACEI or ARB, %787465750.19
 Digoxin, %686864560.72
 Diuretics, %808276810.66
 Beta-blockers, %352319220.04
Ejection fraction, %28.2 ± 11.026.3 ± 12.921.5 ± 9.523.6 ± 7.30.0004
NYHA functional class2.3 ± 0.93.1 ± 0.73.5 ± 0.82.9 ± 0.9< 0.0001
Resting heart rate, beats/min81 ± 1688 ± 1891 ± 2181 ± 200.0004
Systolic blood pressure, mm Hg116 ± 23114 ± 21103 ± 17101 ± 15< 0.0001
Serum sodium, mEq/l138 ± 4137 ± 5136 ± 5137 ± 50.01
Serum creatinine, mg/dl1.3 ± 1.01.4 ± 0.81.5 ± 1.01.3 ± 1.00.40
PCWP (n = 53), mm Hg15.6 ± 7.926.7 ± 6.032.3 ± 6.930.3 ± 4.0< 0.0001
CI (n = 50), mm Hg2.3 ± 0.32.1 ± 0.61.9 ± 0.71.6 ± 0.50.07

*Plus-minus values are means ± SD.

ACEI = angiotensin-converting enzyme inhibitors; ARB = angiotensin receptor blockers; CI = cardiac index; NYHA = New York Heart Association; PCWP = pulmonary capillary wedge pressure.